Gougenheim, France

Jean-Philippe Starck

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2008-2012

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jean-Philippe Starck: Innovator in Pharmaceutical Patents

Introduction

Jean-Philippe Starck is a notable inventor based in Gougenheim, France. He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work primarily focuses on developing innovative compounds for treating various medical conditions.

Latest Patents

Starck's latest patents include the development of benzoxazolone derivatives, which are processes for preparing these compounds and their uses in pharmaceuticals. These derivatives are particularly relevant in the treatment of movement disorders, especially Parkinson's disease. Another significant patent involves indolone-acetamide derivatives, which also includes processes for their preparation and applications in treating epilepsy, seizure disorders, and convulsions.

Career Highlights

Throughout his career, Starck has worked with prominent companies in the pharmaceutical industry, including UCB Pharma and UCB S.A. His expertise in drug development has positioned him as a key player in the advancement of therapeutic solutions.

Collaborations

Starck has collaborated with notable professionals in his field, including Benoît Kenda and Michel Guyaux. These partnerships have contributed to the successful development of his patented inventions.

Conclusion

Jean-Philippe Starck's innovative work in pharmaceuticals highlights his commitment to improving treatment options for patients with movement disorders and epilepsy. His contributions through patents reflect his significant impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…